Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: The EASY-FIT study

Journal of the American College of Cardiology

Volumn 64, Issue 21, 2014, Pages 2207-2217

  Komukai, Kenichi ^a   Kubo, Takashi ^a   Kitabata, Hironori ^a   Matsuo, Yoshiki ^a   Ozaki, Yuichi ^a   Takarada, Shigeho ^a   Okumoto, Yasushi ^b   Shiono, Yasutsugu ^a   Orii, Makoto ^a   Shimamura, Kunihiro ^a   Ueno, Satoshi ^b   Yamano, Takashi ^a   Tanimoto, Takashi ^a   Ino, Yasushi ^a   Yamaguchi, Tomoyuki ^a   Kumiko, Hirata ^a   Tanaka, Atsushi ^b   Imanishi, Toshio ^a   Akagi, Hideharu ^b   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Social Insurance Kinan Hospital   (Japan)

Author keywords

atherosclerosis; macrophage; statin therapy; vulnerable plaque

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MALONDIALDEHYDE-LOW DENSITY LIPOPROTEIN, HUMAN; PYRROLE DERIVATIVE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DYSLIPIDEMIA; FEMALE; FIBROUS CAP THICKNESS; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; UNSTABLE ANGINA PECTORIS; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DOSE RESPONSE; DYSLIPIDEMIAS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

AGED; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSLIPIDEMIAS; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; PYRROLES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84922195405     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.08.045     Document Type: Article

References (18)

1. P.S. Sever, B. Dahlöf, and N.R. Poulter Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) Lancet 361 2003 1149 1158
2. J.C. LaRosa, S.M. Grundy, and D.D. Waters Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
3. P.M. Ridker, C.P. Cannon, and D. Morrow C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
4. S.E. Nissen, E.M. Tuzcu, and P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial JAMA 291 2004 1071 1080
5. S. Okazaki, T. Yokoyama, and K. Miyauchi Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study Circulation 110 2004 1061 1068
6. T. Hiro, T. Kimura, and T. Morimoto Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome. A multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study) Clinical Trials J Am Coll Cardiol 54 2009 293 302
7. M. Takano, K. Mizuno, and S. Yokoyama Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy J Am Coll Cardiol 42 2003 680 686
8. G.J. Tearney, E. Regar, and T. Akasaka Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation J Am Coll Cardiol 59 2012 1058 1072
9. S. Takarada, T. Imanishi, and T. Kubo Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study Atherosclerosis 202 2009 491 497
10. S. Takarada, T. Imanishi, and K. Ishibashi The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome. Follow-up study by optical coherence tomography and intravascular ultrasound J Am Coll Cardiol Intv 3 2010 766 772
11. T. Kubo, T. Imanishi, and S. Takarada Assessment of culprit lesion morphology in acute myocardial infarction. Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy J Am Coll Cardiol 50 2007 933 939
12. S. Tahara, T. Morooka, and Z. Wang Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aorta Arterioscler Thromb Vasc Biol 32 2012 1150 1157
13. Y. Matsuo, T. Kubo, and Y. Okumoto Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease Eur Heart J Cardiovasc Imaging 14 2013 43 50
14. R. Virmani, F.D. Kolodgie, and A.P. Burke Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
15. R. Egede, L.O. Jensen, and H.S. Hansen Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial EuroIntervention 8 2013 1182 1189
16. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
17. S. Kinlay, G.G. Schwartz, and A.G. Olsson High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study Circulation 108 2003 1560 1566
18. G. van Soest, E. Regar, and T.P. Goderie Pitfalls in plaque characterization by OCT: image artifacts in native coronary arteries J Am Coll Cardiol Img 4 2011 810 813